Cours Univo Pharmaceuticals Ltd TEL AVIV STOCK EXCHANGE
Actions
UNVO
IL0010935588
Recherche biotechnologique et médicale
CA 2019 | 0,82 3,13 0,75 | CA 2020 | 33,68 128,14 30,75 | Capitalisation | 75,1 M 286 M 68,56 M |
---|---|---|---|---|---|
Résultat net 2019 | -11 M -41,85 M -10,04 M | Résultat net 2020 | - 0 0 | VE / CA 2019 | 35 543 010 x |
Trésorerie nette 2019 | 22,82 M 86,82 M 20,83 M | Dette nette 2020 | 4,12 M 15,67 M 3,76 M | VE / CA 2020 | 2 352 105 x |
PER 2019 * |
-
| PER 2020 |
-
| Employés | - |
Rendement 2019 * |
-
| Rendement 2020 |
-
| Flottant | 59,28% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Golan Bitton
CEO | Chief Executive Officer | 47 | 04/04/93 |
Jonathan Eilat
IRC | Investor Relations Contact | - | - |
Noam Frakash
AUD | Comptroller/Controller/Auditor | 41 | 01/01/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chaim Hurvitz
CHM | Chairman | 63 | 15/07/19 |
Golan Bitton
CEO | Chief Executive Officer | 47 | 04/04/93 |
Varia. 1 janv. | Capi. | |
---|---|---|
+1,51% | 42,75 Md | |
+49,22% | 41,61 Md | |
+8,57% | 41,34 Md | |
-12,36% | 26,59 Md | |
+8,92% | 25,49 Md | |
-25,13% | 18,12 Md | |
+29,17% | 12,24 Md | |
-3,12% | 11,76 Md | |
+6,35% | 11 Md |